Indiana University School Of Medicine
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1903-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.medicine.iu.edu
Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL
Phase 1
Completed
- Conditions
- Non Hodgkin's Lymphoma
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2014-09-11
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 18
- Registration Number
- NCT00477945
- Locations
- 🇺🇸
Indiana University Cancer Center, Indianapolis, Indiana, United States
A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT
Phase 1
Completed
- Conditions
- Hematologic Malignancies
- First Posted Date
- 2007-05-23
- Last Posted Date
- 2014-09-18
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 18
- Registration Number
- NCT00477542
- Locations
- 🇺🇸
Indiana University Cancer Center, Indianapolis, Indiana, United States
International SMA Patient Registry
Completed
- Conditions
- Muscular Atrophy, Spinal
- First Posted Date
- 2007-04-27
- Last Posted Date
- 2018-08-07
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 3000
- Registration Number
- NCT00466349
- Locations
- 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
Risk of Asthma in Infants With Atopic Dermatitis
Completed
- Conditions
- EczemaAsthmaDermatitis, Atopic
- First Posted Date
- 2007-04-12
- Last Posted Date
- 2013-04-17
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 120
- Registration Number
- NCT00459576
- Locations
- 🇺🇸
Riley Hospital for Children, Indianapolis, Indiana, United States
Functional Connectivity in Mood Regulating Circuit In Bipolar Depression and Mania
Phase 4
Completed
- Conditions
- Bipolar Depression
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2011-09-28
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 60
- Registration Number
- NCT00457054
- Locations
- 🇺🇸
Indiana University Adult Psychiatry Clinic, Indianapolis, Indiana, United States
Serotonin Transporter Genetic Variation and Amygdalar Activation Correlates of Antidepressant Response
Phase 4
Completed
- Conditions
- Depression
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2011-11-15
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 80
- Registration Number
- NCT00456430
- Locations
- 🇺🇸
Indiana University Adult Psychiatry Clinic, Indianapolis, Indiana, United States
Wellbutrin XL Effects on SSRIs Induced Changes
Phase 4
Completed
- Conditions
- DepressionSide EffectsSexual DysfunctionApathy
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2007-10-16
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 15
- Registration Number
- NCT00456820
- Locations
- 🇺🇸
Indiana University Adult Psychiatry Clinic, Indianapolis, Indiana, United States
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
Phase 2
Completed
- Conditions
- Asperger SyndromeAutistic DisorderChild Development Disorders, Pervasive
- Interventions
- Drug: Placebo
- First Posted Date
- 2007-03-28
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 31
- Registration Number
- NCT00453180
- Locations
- 🇺🇸
Riley Hospital, Riley Child and Adolescent Psychiatry Clinic, Indianapolis, Indiana, United States
Assessment of Airway Obstruction in Infants With Lower Respiratory Infections
Not Applicable
Completed
- Conditions
- BronchiolitisRespiratory Syncytial Virus Infections
- Interventions
- Drug: Inhaled primatene will be given as a breathing treatmentOther: Nasal Washing
- First Posted Date
- 2007-02-16
- Last Posted Date
- 2016-06-01
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 59
- Registration Number
- NCT00435994
- Locations
- 🇺🇸
Riley Hospital for Children, Indianapolis, Indiana, United States
Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation
Not Applicable
Completed
- Conditions
- Chronic Kidney DiseaseEndothelial DysfunctionInflammationHypertension
- Interventions
- Drug: Placebo
- First Posted Date
- 2007-01-29
- Last Posted Date
- 2009-06-03
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 24
- Registration Number
- NCT00428246
- Locations
- 🇺🇸
Richard A. Rodebush VA Medical Center, Indianapolis, Indiana, United States